In 1999, we initially reported that our prospective findings indicated that carriers of the most frequent path_BRCA1 variants had lower incidence for infiltrating breast cancer than other path_BRCA1 carriers [3]. This evidence concerns the gene BRCA1 and invasive breast carcinoma.